# Weimu Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/weimu-medical

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Total disclosed funding: $14M
- Latest round: Series A (Dec 6, 2023)
- Investors on record: 6

## About

Established in 2020 and based in Shanghai, China, Medical operates as a medical device developer specializing in interventional medical devices based on biomedical polymers. The founder, Dang Xie, graduated from Fudan University. The company launched polyvinyl alcohol embolization microspheres in March 2022. Varicose closure glue was developed in April 2022. In December 2023, Weimu Medical raised more than CNY 100 million in series A funding.

Weimu Medical mainly provides medical microspheres and extension devices, liquid gels, hydrogels, etc. Its main products are polyvinyl alcohol embolic microspheres, varicose vein closure gel, varicose vein ablation catheters, liquid embolic agents, and other products. The company's devices can be used in oncology, medical aesthetics, and varicose veins. It also developed biomedical polymer materials.

## Funding rounds

- Series A, Dec 6, 2023, $14M — IDG Capital, Sharewin Investment, CS Capital, Woyong Fund, Yunnan Botanee Bio-Technology Group, Huajin Dadao Investment

## Investors

- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A
- Sharewin Investment (https://capitalatlas.ai/funds/sharewin-investment) — Series A
- CS Capital — Series A
- Woyong Fund — Series A
- Yunnan Botanee Bio-Technology Group — Series A
- Huajin Dadao Investment — Series A